intranasal glutathione GSH Science & Research Are Intranasal Drugs the Future

Several engineering approaches aim to extend GHK-Cu's stability and reach

Use bacteriostatic water rather than sterile water to enable multi-dose use from single vials

Our standard of care for low immunological risk kidney transplant patients consisted of induction with basiliximab, and a triple drug immunosuppressive regimen including a calcineurin inhibitor, mycophenolate mofetil and prednisone

EMBO Rep 2010, 11, 68590

However, there are several limitations to these models, including: (1) lengthy observation periods, (2) high cost, (3) difficult genetic manipulations, and (4) ethical concerns regarding prolonged and repeated injury of a large number of mammals